Status:

ACTIVE_NOT_RECRUITING

Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

Centre de Recherche en Sante de Nouna, Burkina Faso

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Malaria Incidence

Seasonal Malaria Chemoprevention

Eligibility:

All Genders

6-59 years

Phase:

NA

Brief Summary

In the Sahel, the malaria and malnutrition seasons overlap during the rainy season, from approximately July through October. Malaria transmission increases due to the rain and collection of standing w...

Eligibility Criteria

Inclusion

  • Children will be eligible for inclusion in the trial if they meet all of the following criteria:
  • Live in the study community
  • Eligible for SMC
  • No allergy to peanuts or cow's milk
  • Able to orally feed
  • Within the eligible age ranges:
  • 6-59 months for passive surveillance
  • 6-24 months for SQ-LNS provision
  • Written informed consent from at least one caregiver
  • Caregiver is at least 18 years of age
  • Children will be recruited during normal distribution (via door-to-door delivery) for SMC, which occurs monthly during the malaria season (July through October).
  • Children ages 3-6 months are eligible for SMC and will be included in nutritional screening and monitoring by default but will not be eligible for SQ-LNS, which is designed for children ages 6-24 months and will not be part of the passive surveillance.
  • A random sample of children ages 6-24 months during the first month of distribution will be asked to participate in an active surveillance cohort. These children will be followed biweekly for screening for malaria with a rapid diagnostic test and temperature and monthly for dried blood spot and anthropometric measurements.

Exclusion

    Key Trial Info

    Start Date :

    July 3 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 30 2026

    Estimated Enrollment :

    438 Patients enrolled

    Trial Details

    Trial ID

    NCT06599593

    Start Date

    July 3 2025

    End Date

    October 30 2026

    Last Update

    November 17 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centre de Recherche en Sante de Nouna

    Nouna, Burkina Faso